Log In
Print this Print this

Nefecon (PL-56)

Also known as: Nefigan

  Manage Alerts
Collapse Summary General Information
Company Pharmalink AB
DescriptionEnteric formulation of budesonide that downregulates the kidney's inflammatory process
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationGlomerulonephritis
Indication DetailsTreat IgA nephropathy
Regulatory Designation U.S. - Orphan Drug (Treat IgA nephropathy);
EU - Orphan Drug (Treat IgA nephropathy)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today